GlaxoSmithKline PLC's consumer health sales grew 4.3% to £1.9bn ($2.63bn) in the fourth quarter on an “earlier and more severe” cold and flu season offset in part by private label competition in the allergy category.
Sanofi, on the other hand, got a consumer sector boost from its allergy product sales during the October-December period...




